 comparative trial reactogenicity immunogenicity Takeda acellular pertussis vaccine tetanus diphtheria toxoids Outcome infants infants children children reactogenicity immunogenicity Takeda acellular pertussis vaccine tetanus diphtheria toxoids infants months infants children months children months Good antibody responses toxin PT filamentous hemagglutinin FHA agglutinogens age groups third fourth doses fourth booster dose mean antibody values seronegative infants months age anti-PT enzyme-linked immunosorbent assay units EU milliliter anti-FHA EU/mL agglutinin titer values seronegative children months age anti-PT EU/mL anti-FHA EU/mL agglutinin titer Reactions immunization minimal drowsiness first dose infants significant differences reactions infants children findings study recent demonstration efficacy vaccine children recent Japanese recommendation age immunization acellular pertussis vaccine tetanus diphtheria toxoids months